ORM-3819 is a novel selective and potent inhibitor of PDE III, promoting cardiac contractility through Ca(2+) sensitization. References: Nagy L, Pollesello P, Haikala H, Végh A, Sorsa T, Levijoki J, Szilágyi S, Edes I, Tóth A, Papp Z, Papp JG. ORM-3819 promotes cardiac contractility through Ca(2+) sensitization in combination with selective PDE III inhibition, a novel approach to inotropy. Eur J Pharmacol. 2016 Mar 15;775:120-9. doi: 10.1016/j.ejphar.2016.02.028. Epub 2016 Feb 9. PubMed PMID: 26872993.

纯度：≥98%

CAS：360794-85-0